SEC Form 4 · accession 0001179110-15-013021
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP, Corp & Med Affairs
Period of report
Sep 1, 2015
Accepted (ET)
Sep 3, 2015 · 3:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2015 | M | 8,625 | $24.295 | A | 146,047 | D | |
| Common Stock | Sep 1, 2015 | M | 1,375 | $23.755 | A | 147,422 | D | |
| Common StockF4 | Sep 1, 2015 | S | 7,905 | $102.3195 | D | 139,517 | D | |
| Common StockF5 | Sep 1, 2015 | S | 3,495 | $103.4922 | D | 136,022 | D | |
| Common StockF6 | Sep 1, 2015 | S | 600 | $104.1118 | D | 135,422 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $23.755 | Sep 1, 2015 | M | 1,375 | D | — | Jan 28, 2020 | Common Stock | 1,375 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $24.295 | Sep 1, 2015 | M | 8,625 | D | — | Jan 26, 2022 | Common Stock | 8,625 | 148,742 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F3The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- F4Sale prices reported for the transactions reported here range from $101.91 to $102.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $102.99 to $103.98. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $104.01 to $104.32. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.